Title Category Credit Event date Costsort descending
Hereditary Cancer Syndromes: From Identifying Patients at Risk to Navigating Patients to Management (EM1908A)
  • AMA
  • Attendance
$0.00 This course is a one hour video-based education opportunity to educate physicians on how to identify individuals at risk for more common and rarer hereditary cancer syndromes, how patients should be managed as there have been recent changes to National Comprehensive Cancer Network (NCCN) guidelines for many specific genes, and the impact of a genetic patient navigator on high-risk patient care. the practice standard used will be NCCN guidelines, but as guidelines are changing rapidly, this event would provide a succinct review to keep learners abreast of new information.
In-Situ Simulation
09/18/2018 $0.00 The UTSW High Reliability Team is offering in-situ simulation in both Clements and Zale hospital units. Through simulation of an emergent and critical patient event and subsequent debriefing, staff and faculty are able to practice their teamwork and communication skills. This safe environment utilizes a high fidelity manikin that simulates patient decompensation. Through debriefing, participants discuss what went well and what could have been done better in regards to teamwork and communication.
EM1901D "Bringing Machine Learning to the Bedside: Focusing Clinical Decision Support with Predictive Modeling" (IM GR-011819)
  • AMA
$0.00 Purpose & Overview
EM1901E "Adipose Tissue in Health and Disease: Why Should We Care?” (IM GR-012519)
  • AMA
$0.00 Purpose & Overview: To discuss and explain the underlying mechanisms responsible for the development of diabetes and the underlying pathophysiological changes in adipose tissue. The adipocyte is a major endocrine cell whose contribution to systemic carbohydrate and lipid homeostasis are frequently underestimated.
EM1902E "Cardiac Amyloidosis: The Zebra is Losing its Stripes" (IM GR-020119)
  • AMA
$0.00 PURPOSE AND OVERVIEW: To discuss the current management strategies for cardiac amyloidosis, including the pathophysiology and prognosis of cardiac amyloidosis, the state-of-the-art diagnostic strategies for cardiac amyloidosis, and the current and new treatments on the horizon for cardiac amyloidosis.
EM1902G "Texas BBQ with a side of glucagon: The Ins and Outs of Eosinophilic Esophagitis" (IM GR-021519)
  • AMA
$0.00 Eosinophilic esophagitis (EoE) is a chronic condition with increasing prevalence worldwide that requires timely detection and treatment to avoid stenosis in the esophagus. Appropriate management of his disease requires awareness and coordination among primary care providers, gastroenterologists, allergists, pathologists and nutritionists. This presentation reviews the pathophysiology, clinical presentation, diagnostic criteria, and management of eosinophilic esophagitis.
Cancer Genetics 2019: Prevention, Testing, and Treatment (RP1903F)
  • AMA
  • Attendance
03/23/2019 $85.00
UT Southwestern Epilepsy Symposium (RP1904A)
  • AMA
  • Attendance
04/27/2019 $100.00 This program will provide a review and update in key areas of epilepsy management. Emphasis will be placed on updates in diagnosis, management, and the most current treatment modalities that have practical applications for neurologists, other clinicians, and health care professionals. 
Physical Medicine & Rehabilitation Scientific Day 2019: Research and Evidence-Based Update on Spine Disorders
  • AMA
  • Attendance
05/03/2019 $115.00 This program is designed to highlight recent scientific advances in Interventional Spine C
What's New in GI 2019 (RP1902B)
  • AMA
  • Attendance
02/16/2019 $175.00 What’s New in GI 2019 will cover novel developments in treatment of achalasia, new medications and treatment algorithms for inflammatory bowel disease, evaluation and management of pancreatic cysts and common issues and new developments in colonoscopy.

Pages